Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2007 by Pacific Pharmaceuticals.
Recruitment status was  Active, not recruiting
Study NCT00366119   Information provided by Pacific Pharmaceuticals

First Received on August 17, 2006.   Last Updated on March 8, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Essential Hypertension
Additional conditions recognized in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Ramipril
Additional drug interventions recognized in this trial
Antihypertensive Agents
More general drug interventions related to this trial
Angiotensin-Converting Enzyme Inhibitors
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Pacific Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services